SIX4, a potential therapeutic target for estrogen receptor-positive breast cancer patients, is associated with low promoter methylation level
Article in Epigenomics (September 2023)
The most recent citing publications are shown below. View all 5 publications that cite this research output on Dimensions.
Topical Calcipotriol Plus Imiquimod Immunotherapy for Nonkeratinocyte Skin Cancers
Article in JID Innovations (August 2023)
A prognostic signature associated with cell senescence predicts survival outcomes and strongly associates with immunotherapy and chemotherapy response in breast cancer
Article in Medicine (June 2023)